Pomalidomide,belantamab mafodotin,dexamethasone
bms,gsk
canadian algonquin pom-bela-dex trial being highlighted at #ims2022 
Multiple Myeloma Lead, Juravinski Cancer Centre
Clinical Investigator
Assistant Professor, McMaster University